The health authorities of France are giving birth to children under the age of 55 who are receiving a first dose of AstraZeneca vaccine for the coronavirus should receive another vaccine for their second dose, debit a very rare rare form of coagulation.
It is hoped that Germany will recommend a similar strategy for people under 60 years of age.
Without embarrassment, the World Health Organization says it is ready to go if it does not recommend this vaccine package and the European Medicines Agency does not recommend that it restrict the use of the AstraZeneca vaccine.
The French authorities say that the vacancy of the British-Swedish company is being considered for its inoculation plan and will be slammed by the mayor’s edad to become reciprocal, and at the moment the hospitals of the paisal battalion have a new incentive for patients -19.
“It’s a vacancy,” said Dominique Le Guludec, president of the French Health Authority. “If we want to win the battle against the virus, we will use all our arms at our disposal.”
Various European countries have decided in recent weeks to imitate the use of the AstraZeneca vaccine in the case of people having advanced debit to the recent evidence that the vaccine powder has been found in rare young people in coagulation.
Since March 19, France has only received AstraZeneca’s vacancy for the 55-year-olds.
More from the midst of France’s public debate over this oath — including the Minister of Health, Olivier Verán — has received the first dose of the vaccine.
The maximum authority of Health of France is the four that maintain the limit of edad at the moment and recommend that the most young people who receive the first dose of the AstraZeneca vaccine use a second dose of Pfizer or Modern.
“It’s a precautionary measure,” Veran told RTL radio broadcaster.